---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013059"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:37:55.744152+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics enters $25M ATM equity offering with Maxim Group

## Summary
- Up to $25M of common stock may be sold at-the-market via Maxim Group as agent.
- Agent commission set at 3% of gross proceeds; $60k legal fee reimbursement at signing.
- Proceeds to be used for working capital and general corporate purposes.
- Agreement dated May 30, 2025; offering under effective Form S-3 (File No. 333-268560).
- Company may terminate agreement at any time with ten business days' notice.

## SEC filing metadata
- accession: 0001641172-25-013059
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000164117225013059/0001641172-25-013059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000164117225013059/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013059
- JSON: https://secwatch.observer/filing/0001641172-25-013059.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.